Dr. Dhananjoy Saha, Kushal Nandi, Amrita Chakraborty and Dr. Dhrubo Jyoti Sen (2021) “Zolgensma: World’s most expensive drug of choice; Survival of Motor Function for the Treatment of Spinal Muscular Atrophy Type 1: https://doi.org/10.54037/WJPS.2021.91104”, World Journal of Pharmaceutical Sciences, 9(11), pp. 83–86. Available at: https://wjpsonline.com/index.php/wjps/article/view/zolgensma-motor-function-spinal-muscular-atrophy (Accessed: 3 October 2022).